结缔组织病患儿行保留瓣膜的主动脉根部置换术:主动脉事件的长期风险
该单中心回顾性分析纳入2002至2021年接受保留瓣膜的主动脉根部置换术(VSRR)的24例结缔组织病(CTD)患儿,中位随访8.3年。15年生存率为91.7%,术后10年主动脉瓣反流再手术累积发生率为15.6%,主动脉瘤或夹层再手术累积发生率为29.1%,无主要终点事件生存率为53.1%。作者认为需对低龄手术患儿加强监测。
要点
- 24例CTD患儿行VSRR,无早期死亡,15年生存率91.7%。
- 术后10年主动脉瓣反流再手术累积发生率为15.6%。
- 术后10年主动脉瘤或夹层再手术累积发生率为29.1%,10年无主要终点事件生存率53.1%。
核心结论
- 对CTD患儿因主动脉根部扩张行VSRR可获得良好的长期生存和较低的主动脉瓣反流再手术率。
- 但部分患者后期出现主动脉瘤或夹层,可能需要仔细监测,尤其是低龄接受VSRR者。
研究设计与样本
- 回顾性分析单中心2002至2021年接受VSRR的儿童CTD患者。
- 共纳入24例患儿,中位随访8.3年,最长20.7年。
- 主要终点为全因死亡和心血管再手术的复合事件。
主要发现
- 24例患儿中位手术年龄14.4岁,马方综合征19例(79.2%),Loeys-Dietz综合征5例(20.8%)。
- 无早期死亡,15年生存率为91.7%。
- VSRR术后10年,主动脉瓣反流再手术累积发生率为15.6%,主动脉瘤或夹层再手术累积发生率为29.1%。
- 10年无主要终点事件生存率为53.1%。
- Cox多因素分析显示,手术时年龄较小(HR 1.279,95%CI 1.086-1.505,P=.003)和13岁前接受VSRR(HR 5.005,95%CI 1.146-21.850,P=.032)是主要终点的独立预后因素。
临床怎么用
- 作者认为,对CTD患儿因主动脉根部扩张行VSRR后可能需要仔细监测,尤其是低龄接受手术者。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Cardiovascular involvement in pediatric patients with connective tissue disease (CTD) is life-threatening, with aortic root dilatation being the most prevalent cardiovascular abnormality. We attempted to determine long-term outcomes of valve-sparing root replacement (VSRR) in this group, including cardiovascular reoperations for aortic aneurysm and dissection. METHODS: We conducted a retrospective analysis of pediatric patients with CTD who received VSRR in a single center from 2002 to 2021. The primary end point was a composite event of all-cause death and cardiovascular reoperations. The median follow-up duration was 8.3 years, with a maximum of 20.7 years. RESULTS: The median age of 24 pediatric patients who had VSRR was 14.4 years. Marfan syndrome and Loeys-Dietz syndrome affected 19 (79.2%) and 5 (20.8%) patients, respectively. There was no early death. The 15-year survival rate was 91.7%. At 10 years after VSRR, the cumulative incidence of reoperation for aortic regurgitation was 15.6%, and for aortic aneurysm or dissection, it was 29.1%. The 10-year rate of freedom from the primary end point was 53.1%. The Cox multivariable analysis revealed younger age at surgery (hazard ratio, 1.279; 95% confidence interval, 1.086-1.505; P = .003) and VSRR before 13 years of age (hazard ratio, 5.005; 95% confidence interval, 1.146-21.850; P = .032) as independent prognostic factors for the primary endpoint. CONCLUSIONS: VSRR for aortic root dilatation in pediatric patients with CTD demonstrated good long-term survival and low reoperation rates for aortic regurgitation. However, several patients developed later aortic aneurysm or dissection, and careful surveillance may be required, particularly in those who received VSRR at younger age.
引用
- Park I, Yang JH, Sung K, et al. Valve-sparing root replacement in children with connective tissue disease: Long-term risk of aortic events. J Thorac Cardiovasc Surg. 2023. PMID: 37890658. doi:10.1016/j.jtcvs.2023.10.041
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。